Croft-Leominster’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $605K | Sell |
17,607
-84,437
| -83% | -$2.9M | 0.57% | 51 |
|
|
2017
Q3 | $3.46M | Sell |
102,044
-1,786
| -2% | -$60.5K | 0.82% | 49 |
|
|
2017
Q2 | $3.31M | Buy |
103,830
+107
| +0.1% | +$3.41K | 0.78% | 53 |
|
|
2017
Q1 | $3.37M | Buy |
+103,723
| New | +$3.37M | 0.8% | 48 |
|
|
2016
Q4 | – | Sell |
-108,148
| Closed | -$3.48M | – | 50 |
|
|
2016
Q3 | $3.48M | Sell |
108,148
-108,286
| -50% | -$3.48M | 0.86% | 48 |
|
|
2016
Q2 | $7.23M | Sell |
216,434
-4,090
| -2% | -$137K | 1.63% | 15 |
|
|
2016
Q1 | $6.2M | Sell |
220,524
-10,608
| -5% | -$298K | 1.41% | 23 |
|
|
2015
Q4 | $7.08M | Sell |
231,132
-5,138
| -2% | -$157K | 1.52% | 16 |
|
|
2015
Q3 | $7.04M | Sell |
236,270
-12,596
| -5% | -$375K | 1.63% | 16 |
|
|
2015
Q2 | $7.92M | Buy |
248,866
+4,999
| +2% | +$159K | 1.53% | 16 |
|
|
2015
Q1 | $8.05M | Sell |
243,867
-3,643
| -1% | -$120K | 1.48% | 16 |
|
|
2014
Q4 | $7.32M | Sell |
247,510
-3,258
| -1% | -$96.3K | 1.28% | 24 |
|
|
2014
Q3 | $7.04M | Buy |
250,768
+594
| +0.2% | +$16.7K | 1.24% | 25 |
|
|
2014
Q2 | $7.05M | Sell |
250,174
-29,163
| -10% | -$821K | 1.19% | 28 |
|
|
2014
Q1 | $8.51M | Sell |
279,337
-35,117
| -11% | -$1.07M | 1.35% | 22 |
|
|
2013
Q4 | $9.14M | Sell |
314,454
-22,034
| -7% | -$640K | 1.38% | 21 |
|
|
2013
Q3 | $9.17M | Sell |
336,488
-104,260
| -24% | -$2.84M | 1.5% | 14 |
|
|
2013
Q2 | $11.7M | Buy |
+440,748
| New | +$11.7M | 1.72% | 14 |
|